GGrantIndex
Sort

261,768 grants matching gene therapy

A consortium effort to translate therapies for neurological diseases via an ex vivo organotypic platform

$1,117,537
Shawn Hingtgen · Univ Of North Carolina Chapel Hill · U01 · FY2024 · TR

Niche-induced signaling in HSCP transplantation

$1,117,451
Leslie Eric Silberstein · Boston Children'S Hospital · P01 · FY2014 · HL

Cancer dependencies associated with genomic alterations and targeted by small mol

$1,117,372
Stuart L Schreiber · Broad Institute, Inc. · U01 · FY2015 · CA

Targeting DNA Methylation and the Cancer Epigenome

$1,117,337
Peter A Jones · Van Andel Research Institute · R35 · FY2020 · CA

Targeting DNA Methylation and the Cancer Epigenome

$1,117,337
Peter A Jones · Van Andel Research Institute · R35 · FY2021 · CA

Pathways that Suppress or Accelerate Premalignant Progression of Squamous Cancer

$1,117,299
Stuart H. Yuspa · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA

Interacting Signaling Pathways that Initiate Squamous Cell Carcinogenesis

$1,117,299
Stuart H. Yuspa · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA

Reversing Tissue Fibrosis to Improve Immune Reconstitution in HIV

$1,117,257
Timothy W Schacker · University Of Minnesota · U01 · FY2014 · AI

Tumor Plasticity

$1,117,200
Dario C. Altieri · Wistar Institute · R35 · FY2022 · CA

Tumor Plasticity

$1,117,200
Dario C. Altieri · Wistar Institute · R35 · FY2023 · CA

Immune Regulation in HCT

$1,117,156
Robert S Negrin · Stanford University · P01 · FY2014 · CA

IL-6 Trans-signaling increases vulnerability to Postoperative Cognitive Decline in Aging and Alzheimers Disease

$1,117,062
Mervyn Maze · University Of California, San Francisco · R01 · FY2024 · AG

ONCOGENES IN CANCER ETIOLOGY AND PROGRESSION

$1,116,986
Thomas Jefferson University · P01 · FY2002 · CA

Understanding the Role of the Host Response in HIVSIV Infection

$1,116,963
Genoveffa Franchini · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA

Regulatory Crosstalk Between Human Endogenous Retroviruses, HIV, and EBV, in Lymphoma

$1,116,963
Douglas F Nixon · Feinstein Institute For Medical Research · R01 · FY2024 · CA

Pathways that Suppress or Accelerate Premalignant Progression of Squamous Cancer

$1,116,803
Stuart H. Yuspa · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

Molecular Correlates Of Human Ca2+ Channel Regulation

$1,116,677
Nikolai Soldatov · Aging · Z01 · FY2007 · AG

B-CELL TARGETED INDUCTION TO IMPROVE OUTCOMES IN PEDIATRIC LUNG TRANSPLANTATION

$1,116,525
Stuart C Sweet · Washington University · U01 · FY2015 · AI

Tumor Microenvironment in Cancer Progression

$1,116,420
Rosandra Kaplan · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Biomarkers and Therapeutic Targets in Tumor Microenvironment and Metastasis

$1,116,420
Rosandra Kaplan · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Discovery and/or Validation of Pharmacodynamic Markers

$1,116,392
Sulayman D Dib-Hajj · Marine Biological Laboratory · U19 · FY2021 · NS

Epigenetics Biomarker of Post Operative Delirium and Long Term Cognitive Decline among Elderly Dementia Patients

$1,116,265
Gen Shinozaki · Stanford University · R01 · FY2025 · AG

Comparative Mammalian Genomics

$1,116,252
Elaine Ostrander · National Human Genome Research Institute · ZIA · FY2016 · HG

MOLECULAR CLASSIFICATION OF B-CELL LYMPHOMA

$1,116,146
University Of Nebraska Medical Center · U01 · FY2001 · CA

Telomere Diseases and Other Constitutional and Acquired Genetic Disorders of Hematopoiesis

$1,116,066
Neal S Young · National Heart, Lung, And Blood Institute · ZIA · FY2021 · HL